Cargando…
Ebola returns: back to square one
Autor principal: | The Lancet Infectious Diseases |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560756/ https://www.ncbi.nlm.nih.gov/pubmed/36244348 http://dx.doi.org/10.1016/S1473-3099(22)00678-8 |
Ejemplares similares
-
Back to the future—of immunisations
por: The Lancet Infectious Diseases
Publicado: (2023) -
Time for Africa to future-proof, starting with COVID-19
por: The Lancet Infectious Diseases
Publicado: (2022) -
Transitioning to endemicity with COVID-19 research
por: The Lancet Infectious Diseases
Publicado: (2022) -
Emerging SARS-CoV-2 variants: shooting the messenger
por: The Lancet Infectious Diseases
Publicado: (2022) -
Why hybrid immunity is so triggering
por: The Lancet Infectious Diseases
Publicado: (2022)